You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Suppliers and packagers for BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE


✉ Email this page to a colleague

« Back to Dashboard


BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Eugia Pharma BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895 ANDA Eugia US LLC 55150-167-10 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-167-10) / 10 mL in 1 VIAL, SINGLE-DOSE 2013-11-05
Eugia Pharma BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895 ANDA Eugia US LLC 55150-168-30 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-168-30) / 30 mL in 1 VIAL, SINGLE-DOSE 2013-11-05
Eugia Pharma BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895 ANDA Eugia US LLC 55150-169-10 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-169-10) / 10 mL in 1 VIAL, SINGLE-DOSE 2013-11-05
Eugia Pharma BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895 ANDA Eugia US LLC 55150-170-30 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-170-30) / 30 mL in 1 VIAL, SINGLE-DOSE 2013-11-05
Eugia Pharma BUPIVACAINE HYDROCHLORIDE PRESERVATIVE FREE bupivacaine hydrochloride INJECTABLE;INJECTION 203895 ANDA Eugia US LLC 55150-171-10 25 VIAL, SINGLE-DOSE in 1 CARTON (55150-171-10) / 10 mL in 1 VIAL, SINGLE-DOSE 2013-11-05
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for the Pharmaceutical Drug: Bupivacaine Hydrochloride, Preservative-Free

Last updated: July 29, 2025


Introduction

Bupivacaine Hydrochloride, preservative-free, is a local anesthetic widely utilized in surgical, obstetric, and dental procedures due to its prolonged duration of action and efficacy in nerve blockade. Its preservative-free formulation ensures compatibility with sensitive tissues and reduces risk of allergic reactions, making it suitable for epidural, spinal, and local infiltration anesthesia. Given its critical role, identifying reliable suppliers is essential for healthcare providers, pharmaceutical companies, and distributors seeking high-quality, compliant products.


Overview of the Market for Bupivacaine Hydrochloride, Preservative-Free

The market for injectable local anesthetics involves both multinational pharmaceutical giants and specialized contract manufacturing organizations (CMOs). The demand for preservative-free formulations has increased owing to safety profiles, especially in epidural and spinal anesthesia, where preservatives may cause neurotoxicity (source: [2]).

The key considerations for suppliers include regulatory compliance, manufacturing standards (GMP), product stability, and global distribution capabilities. Countries with stringent regulations such as the US (FDA), European Union (EMA), and Japan (PMDA) stipulate rigorous testing and validation for injectable drugs.


Major Suppliers of Bupivacaine Hydrochloride, Preservative-Free

1. AstraZeneca

Overview:
AstraZeneca remains a leading manufacturer of Bupivacaine Hydrochloride formulations, including preservative-free options. Their drug, "Marcaine," offers a preservative-free version suitable for epidural administration. AstraZeneca adheres to strict GMP standards and has extensive distribution channels globally.

Product Details:

  • Formulation: 0.25%, 0.5%, 0.75% concentrations
  • Packaging: Ampoules and pre-filled syringes
  • Regulatory Status: Approved across multiple regions including the US, Europe, and Asia

Strengths:

  • Proven product quality and stability
  • Global reach, reliable supply chain
  • Strong regulatory compliance

2. Hikma Pharmaceuticals

Overview:
Hikma is a prominent supplier of injectable anesthetics, including preservative-free Bupivacaine. They emphasize high purity standards and innovative sterile manufacturing processes.

Product Details:

  • Formulations: 0.25% and 0.5% Bupivacaine Hydrochloride, preservative-free
  • Packaging: Vials and pre-filled syringes
  • Regulatory Status: Approved in key markets including the US (FDA), Europe (EMA), and Middle East

Strengths:

  • Competitive pricing
  • Global manufacturing facilities compliant with GMP standards
  • Focus on quality and safety

3. Hospira (a Pfizer company)

Overview:
Hospira specializes in sterile injectable drugs, including Bupivacaine Hydrochloride, preservative-free formulations. Their products are well-regarded for consistency and safety.

Product Details:

  • Formulations: 0.25% and 0.5% solutions, preservative-free
  • Packaging: Flasks, vials, pre-filled syringes
  • Regulatory Status: Widely approved globally, including US and Europe

Strengths:

  • Extensive infrastructure for sterile manufacturing
  • Strong reputation for compliance and quality control

4. Fresenius Kabi

Overview:
Fresenius Kabi’s portfolio incorporates local anesthetics including preservative-free Bupivacaine. They focus on reliable supply and global distribution.

Product Details:

  • Formulations: 0.25%, 0.5%, 0.75% solutions
  • Packaging: Ampoules, vials, pre-filled syringes
  • Regulatory Status: Approved in multiple regions with certification for GMP compliance

Strengths:

  • Focus on safety and transparency
  • Proven track record for injectable pharmaceuticals

5. Teva Pharmaceuticals

Overview:
Teva provides generic injectable anesthetics, including preservative-free Bupivacaine, with emphasis on quality and affordability.

Product Details:

  • Formulations: 0.25%, 0.5% concentrations
  • Packaging: Vials, pre-filled syringes
  • Regulatory Status: Approved globally, including US (FDA) and Europe (EMA)

Strengths:

  • Competitive pricing strategy
  • Wide distribution network

Emerging and Contract Manufacturing Suppliers

For organizations seeking custom formulations or higher flexibility, CMOs such as Fannin and Baxter offer manufacturing capabilities for preservative-free Bupivacaine Hydrochloride. These partners support regulatory submissions and supply chain resilience, especially during supply chain disruptions.

Selection Criteria for Suppliers

  • Regulatory approval: Must meet local and international standards (FDA, EMA, PMDA, etc.).
  • Manufacturing quality: GMP compliance, batch consistency, sterility assurance.
  • Supply reliability: Capacity for large-scale and long-term supply.
  • Product stability: Shelf-life, compatibility with packaging.
  • Pricing and lead times: Competitive pricing models with minimal delivery delays.

Conclusion

Securing reliable suppliers for preservative-free Bupivacaine Hydrochloride demands a comprehensive assessment of product quality, regulatory compliance, and supply chain robustness. Major pharmaceutical firms such as AstraZeneca, Hikma, Hospira, Fresenius Kabi, and Teva dominate this market, offering proven, regulatory-approved formulations suitable for various clinical needs. Emerging contract manufacturers can supplement supply chains, providing customization and potential cost advantages.


Key Takeaways

  • Leading global suppliers of preservative-free Bupivacaine Hydrochloride include AstraZeneca, Hikma, Hospira, Fresenius Kabi, and Teva.
  • Ensure supplier compliance with GMP and regulatory approvals relevant to target markets.
  • Consider scalability, delivery timelines, and product stability in supplier selection.
  • Contract manufacturing organizations offer flexibility for custom formulations or supply chain diversification.
  • Maintaining diversified supplier relationships mitigates supply risks and enhances operational resilience.

FAQs

1. What are the main reasons for choosing preservative-free Bupivacaine Hydrochloride?
Preservative-free formulations reduce the risk of neurotoxicity and allergic reactions, making them preferred for epidural, spinal, and sensitive tissue injections.

2. Are there regional differences in supplier availability?
Yes, regional regulations and manufacturing facilities influence supplier availability. Large multinational firms typically have global distribution, while regional suppliers may focus on local markets.

3. How can I verify the quality of Bupivacaine Hydrochloride from a supplier?
Verify regulatory approvals, GMP compliance certificates, batch testing reports, and request reference audits or certifications.

4. What should I consider when sourcing preservative-free formulations from CMOs?
Assess their manufacturing standards, regulatory track record, capacity, lead times, and willingness to support custom formulation needs.

5. How does market competition impact pricing for Bupivacaine Hydrochloride?
High competition among established suppliers often results in competitive pricing; however, supply chain disruptions can influence costs temporarily.


References

[1] European Medicines Agency. Bupivacaine information. EMA, 2022.
[2] American Society of Anesthesiologists. Safety profile of preservative-free local anesthetics. ASA Guidelines, 2021.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.